Treatment-specific consents

Required safety disclosures for specific clinical pathways. Members acknowledge these documents via e-signature checkbox during clinical intake.

• GLP-1 Informed Consent

  Required acknowledgments before GLP-1 receptor agonist treatment through NuraRx.
• Sexual Health Informed Consent

  Required acknowledgments before sexual health treatment through NuraRx.
• NAD+ Informed Consent

  Required acknowledgments before NAD+ supplementation through NuraRx.
• Sermorelin / Peptide Informed Consent

  Required acknowledgments before peptide therapy through NuraRx.